Synapse - Addition of tocilizumab to cyclosporine-a/ mycophenolate mofetil (CSA/MMF) graft-vs-host disease (GVHD) prophylaxis significantly abrogates pre-engraftment syndrome (PES) & severe acute GVHD after adult double unit cord blood transplantation (dCBT)

Addition of tocilizumab to cyclosporine-a/ mycophenolate mofetil (CSA/MMF) graft-vs-host disease (GVHD) prophylaxis significantly abrogates pre-engraftment syndrome (PES) & severe acute GVHD after adult double unit cord blood transplantation (dCBT) Meeting Abstract

Authors:	Politikos, I.; Maloy, M. A.; Devlin, S. M.; Naputo, K.; Bhatt, V.; Skinner, K.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Hanash, A. M.; Jakubowski, A. A.; Papadopoulos, E. B.; Perales, M.; Peled, J. U.; Sauter, C. S.; Scordo, M.; Shah, G. L.; Tamari, R.; Ponce, D. M.; Barker, J. N.
Abstract Title:	Addition of tocilizumab to cyclosporine-a/ mycophenolate mofetil (CSA/MMF) graft-vs-host disease (GVHD) prophylaxis significantly abrogates pre-engraftment syndrome (PES) & severe acute GVHD after adult double unit cord blood transplantation (dCBT)
Meeting Title:	Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR
Journal Title:	Biology of Blood and Marrow Transplantation
Volume:	26
Issue:	3 Suppl.
Meeting Dates:	2020 Feb 19-23
Meeting Location:	Orlando, FL
ISSN:	1083-8791
Publisher:	Elsevier Inc.
Date Published:	2020-03-01
Start Page:	S30
Language:	English
ACCESSION:	WOS:000516887900037
PROVIDER:	wos
DOI:	10.1016/j.bbmt.2019.12.100
Notes:	Meeting Abstract: 36 -- Source: Wos